Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

about

Commentary: The changing scenario of cluster endophthalmitis

P2860

Q58806274-6AD693E9-D639-4439-9857-FB51E5F8A481

P2860

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

Item

http://www.wikidata.org/entity/Q47406772

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

@en

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

@nl

type

Item

label

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

@en

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

@nl

prefLabel

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

@en

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

@nl

P1476

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

@en

P2093

Anurag Shandil

http://www.w3.org/2001/XMLSchema#string

Rajiv Garg

http://www.w3.org/2001/XMLSchema#string

Sarita Beri

http://www.w3.org/2001/XMLSchema#string

P2860

Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

Endophthalmitis caused by Stenotrophomonas maltophilia.

Stenotrophomonas maltophilia endophthalmitis caused by surgical equipment contamination: an emerging nosocomial infection.

Post-cataract endophthalmitis caused by multidrug-resistant Stenotrophomonas maltophilia: clinical features and risk factors.

Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.

Bimanual assisted eyelid retraction technique for intravitreal injections.

P304

1166-1171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/IJO.IJO_314_17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29133644

http://www.w3.org/2001/XMLSchema#string

P932

5700586

http://www.w3.org/2001/XMLSchema#string

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

about

P2860

P2860

Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932